NCT02685072View on ClinicalTrials.gov

Progesterone Augmentation of Nicotine Replacement Therapy Study

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

April 7, 2016

Primary Completion Date

December 18, 2017

Study Completion Date

March 12, 2018

Conditions
Smoking Cessation
Interventions
DRUG

Progesterone (200 mgs BID)

Transdermal Nicotine Patch (TNP) + Progesterone

DRUG

Placebo

TNP + Placebo

Trial Locations (1)

06510

Yale School of Medicine, Department of Psychiatry, New Haven

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Yale University

OTHER

NCT02685072 - Progesterone Augmentation of Nicotine Replacement Therapy Study | Biotech Hunter | Biotech Hunter